• The Weight-Loss Gold Rush: Legal and Regulatory Implications

  • 2024/07/11
  • 再生時間： 17 分
  • ポッドキャスト

The Weight-Loss Gold Rush: Legal and Regulatory Implications

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:
    • Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
    • How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs
    • What needs to be done for GLP-1s to be covered
    • Steps companies developing weight-loss medications should take to ensure responsible and ethical practice
    • Advice for investors and financiers who are considering entering the weight-loss medication market
    続きを読む 一部表示

あらすじ・解説

Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:
  • Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
  • How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs
  • What needs to be done for GLP-1s to be covered
  • Steps companies developing weight-loss medications should take to ensure responsible and ethical practice
  • Advice for investors and financiers who are considering entering the weight-loss medication market
生物科学
続きを読む 一部表示

The Weight-Loss Gold Rush: Legal and Regulatory Implicationsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。